| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:RORγt/DHODH-IN-2
CAS:2641758-86-1
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Methanone, [4-[[3-(2-benzothiazolylamino)-2-methylphenyl]methyl]-1-piperazinyl]cyclopentyl- manufacturers
- RORγt/DHODH-IN-2
-
- $1520.00 / 25mg
-
2025-10-27
- CAS:2641758-86-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Methanone, [4-[[3-(2-benzothiazolylamino)-2-methylphenyl]methyl]-1-piperazinyl]cyclopentyl- Basic information |
| | Methanone, [4-[[3-(2-benzothiazolylamino)-2-methylphenyl]methyl]-1-piperazinyl]cyclopentyl- Chemical Properties |
| Boiling point | 609.9±65.0 °C(Predicted) | | density | 1.270±0.06 g/cm3(Predicted) | | pka | 6.17±0.10(Predicted) |
| | Methanone, [4-[[3-(2-benzothiazolylamino)-2-methylphenyl]methyl]-1-piperazinyl]cyclopentyl- Usage And Synthesis |
| Uses | RORγt/DHODH-IN-2 (compound 1) is a potent dual RORγt/DHODH inhibitor. RORγt/DHODH-IN-2 can be used for inflammatory bowel disease (IBD) research[1]. | | References | [1] Ji-An Chen, et al. Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease. J Med Chem. 2022 Jan 13;65(1):592-615. DOI:10.1021/acs.jmedchem.1c01746 |
| | Methanone, [4-[[3-(2-benzothiazolylamino)-2-methylphenyl]methyl]-1-piperazinyl]cyclopentyl- Preparation Products And Raw materials |
|